An Experimental Study to Compare Treatment Response and Toxicities of Concurrent Chemoradiation With Weekly Cisplatin and Three Weekly Cisplatin in Locally Advanced Head and Neck Cancer.
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Head and Neck Squamous Cell Carcinoma
Related studies linked through entity extraction aliases.
Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Safety Study of SGN-CD47M in Patients With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
INRT-AIR: A Prospective Phase II Study of Involved Nodal Radiation Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Expression & Epigenetic Silencing of MicroRNA for Predicting Therapeutic Response and Prognosis of HPV-negative HNSCC
- Status
- COMPLETED
- Phase
- N/A
Cell-free Tumor DNA in Head and Neck Cancer Patients
- Status
- UNKNOWN
- Phase
- NA
Liquid Biopsy in Head and Neck Cancer
- Status
- UNKNOWN
- Phase
- N/A
Neoadjuvant Cemiplimab for the Treatment of Resectable NSCLC, HCC, and HNSCC in Adult Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Detection of Circulating Tumor DNA in p16- Locally Advanced Head Neck Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- NA
Preoperative Immune Checkpoint Inhibitor for Patients With Primary Untreated or Recurrent/Metastatic SCCHN
- Status
- COMPLETED
- Phase
- PHASE2
SCT200 Plus Platinum-based Chemotherapy in Head and Neck Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Individualized Radiation Dose Prescription in HNSCC Based on F-MISO-PET Hypoxia-Imaging
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Role of Microbiome as a Biomarkers in Locoregionally-Advanced Oropharyngeal Squamous Cell Carcinoma 2
- Status
- COMPLETED
- Phase
- NA
Validation of USPIO-enhanced MRI for Detection of Lymph Node Metastases in Head and Neck Carcinoma
- Status
- UNKNOWN
- Phase
- NA
Study of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck Cancer
- Status
- TERMINATED
- Phase
- PHASE1
IPI-549 in Patients With Locally Advanced HPV+ and HPV- Head and Neck Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Vaccination With Flt3L, Radiation, and Poly-ICLC
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
SCT200 Injection in Patients With Head and Neck Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2